Synergistic efficacy of recombinant human granulocyte colony-stimulating factor and amphotericin B against disseminated candidosis in non neutropenic mice

Journal de Mycologie Medicale

Volumn 6, Issue 2, 1996, Pages 43-48

  Herbrecht, R ^a   Waller, J ^b   Koenig, H ^b   Morier, P ^b   Letscher, V ^b  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

amphotericin B; Candida albicans; candidosis; experimental disease; granulocyte colony stimulating factor; lenograstim; mice

Indexed keywords

AMPHOTERICIN B; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029839965     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bodey GP. Fungal infection and fever of unknown origin in neutropenic patients. Am J Med 1986;80(suppl. C):112-9.
2. Bodey GP, Anaissie E, Guttermann J, Vadhan-Raj S. Role of granulocyte-macrophage colony-stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Infect Dis 1993;17:705-7.
3. Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L et al. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med 1981;71:59-66.
4. Densen P, Clark RA, Nauseef WM. Granulocytic phagocytes. In: Principles and practice of infectious diseases. Edited by GL Mandell, JE Bennet, R Dolin, Churchill Livingston, New York 1995, p. 78-101.
5. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379-90.
6. Matsumoto M, Matsubara S, Yokota T. Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rG-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone. J Antimicrob Chemother 1991;28:447-53.
7. Mayer P, Schütze E, Lam C, Kricek F, Liehl E. Recombinant mutine granulocyte-macrophage colony-stimulating factor augments neutrophil recovery and enhances resistance to infections in myelosuppressed mice. J Infect Dis 1991;163:584-90.
8. Nemunaitis J, Meyers JD, Buckner CD, Shannon-Dorcy K, Mori M, Shulman H et al. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections. Blood 1991;78:907-13.
9. Nemunaitis J, Shannon-Dorcy K, Appelbaum FR, Meyers J, Owens A, Day R et al. Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 1993;82:1422-7.
10. Polak-Wyss A. Protective effect of human granulocyte colony stimulating factor (hG-CSF) on Candida infections in normal and immunosuppressed mice. Mycoses 1991;34:109-18.
11. Polak-Wyss A. Protective effect of human granulocyte colony-stimulating factor (hG-CSF) on Cryptococcus and Aspergillus infections in normal and immunosuppressed mice. Mycoses 1991;34:205-15.
12. Rex JH, Bennett JE, Sugar AM, Pappas PG, Van der Horst CM, Edwards JE et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-30.
13. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991;163:579-83.
14. Roilides E, Pizzo PA. Modulation of host defenses by cytokines: evolving adjuncts in prevention and treatment of serious infections in immunocompromised hosts. Clin Infect Dis 1993;15:508-24.
15. Schaffner A. Experimental basis for the clinical epidemiology of fungal infections. A review. Mycoses 1989;32:499-515.
16. Stein DK, Sugar AM. Fungal infections in the immunocompromised host. Diagn Microbiol Infect Dis 1989;12:221-8.
17. Steinshamm S, Bergh K, Waage A. Effects of stem cell factor and granulocyte colony-stimulating factor on granulocyte recovery and Candida albicans infection in granulopenic mice. J Infect Dis 1993;168:1444-8.
18. Yamamoto Y, Uchida K, Klein TW, Friedman H, Yamaguchi H. Immunomodulators and fungal infections: use of antifungal drugs in combination with G-CSF. In: Microbial infections. Edited by H. Friedman, Plenum Press, New York 1992, p. 231-41.